NASDAQ · Biotechnology

scPharmaceuticals Inc. (SCPH) Stock

$5.67 +0.00% NASDAQ: SCPH Healthcare

scPharmaceuticals Inc. is a pharmaceutical firm dedicated to developing and commercializing a variety of medicinal products.

Valuation

MetricValue
Price$5.67
Market Cap$302.20M
P/E Ratio-7.99
P/B Ratio-14.29
P/S Ratio10.87
EPS (TTM)$-1.91
52-Week High$6.28
52-Week Low$1.94
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE285.64%
ROA-47.06%
ROCE-53.57%
Gross Margin69.48%
Operating Margin-115.32%
Net Margin-135.88%
Debt/Equity-2.46
Current Ratio3.85

Annual Financials (USD)

Metric20202021202220232024
Revenue$0$0$0$14.0M$36.0M
Operating Profit$-30.0M$-26.0M$-36.0M$-55.0M$-65.0M
Net Profit$-32.0M$-28.0M$-37.0M$-55.0M$-85.0M
EPS$-1.31$-1.02$-1.30$-1.42$-1.91
Op Margin———-407.5%-178.3%

Balance Sheet (USD)

Metric20202021202220232024
Total Assets$109.0M$79.0M$124.0M$94.0M$108.0M
Total Liabilities$27.0M$23.0M$52.0M$57.0M$94.0M
Cash$72.0M$74.0M$71.0M$47.0M$76.0M
Borrowings$20.0M$18.0M$37.0M$40.0M$53.0M

Latest News

Horizon Bancorp Q2 Earnings, Revenue Rise MT Newswires · Jul 22, 2026 4 Leadership Habits That Build Sustainable Operational Standards FSR · Jul 22, 2026 Century Communities Q2 Adjusted Earnings, Revenue Fall MT Newswires · Jul 22, 2026 Filing of Leven Star Reef Technical Report GlobeNewswire · Jul 22, 2026 Home BancShares, Inc. Announces Increase in Quarterly Dividend GlobeNewswire · Jul 22, 2026

Cash Flow (USD)

Metric20202021202220232024
Operating Cash Flow$-28.0M$-27.0M$-35.0M$-59.0M$-71.0M
Investing Cash Flow$-33.0M$32.0M$-46.0M$20.0M$29.0M
Financing Cash Flow$0$0$0$1.0M$20.0M
Net Cash Flow$-1.0M$2.0M$-3.0M$-24.0M$29.0M
Free Cash Flow$-28.0M$-27.0M$-35.0M$-59.0M$-71.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.37
EV / EBITDA-9.00
FCF Yield-11.00%
Quick Ratio3.14
Interest Coverage-11.50
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CKPTCheckpoint Therapeutics, Inc. $4.26 +0.00% -3.00 $367.72M 0.00%
CLYM $14.00 +0.00% -11.77 $801.68M 0.00%
INZYInozyme Pharma, Inc. $4.00 +0.25% -2.47 $258.25M 0.00%
LAB $0.87 -3.27% -5.30 $339.79M 0.00%
ORTXOrchard Therapeutics plc $16.70 +0.30% -27.38 $380.11M 0.00%

About scPharmaceuticals Inc.

scPharmaceuticals Inc. is a pharmaceutical firm dedicated to developing and commercializing a variety of medicinal products. Its primary investigational therapy, FUROSCIX, is a specialized formulation of furosemide delivered through an on-body infusor, intended for managing congestion in heart failure patients. The company's pipeline also encompasses scCeftriaxone, an antibiotic aimed at treating infections caused by both gram-positive and gram-negative bacteria, as well as the scCarbapenem program, another antibiotic designed for gram-negative bacterial infections. Additionally, scPharmaceuticals has entered into a collaboration agreement with West Pharmaceutical Services, Inc. for the advancement of a single-use SmartDose device. Founded in 2013, the company's main operations are based in Burlington, Massachusetts.

scPharmaceuticals Inc. is headquartered in US.

scPharmaceuticals Inc. (SCPH) stock trades at $5.67 with a market capitalization of $302.20M. The stock is valued at a price-to-earnings (P/E) ratio of -7.99, price-to-book of -14.29, price-to-sales of 10.87. Over the past 52 weeks the stock has ranged between $1.94 and $6.28, and currently trades 9.7% below its 52-week high.

On profitability, scPharmaceuticals Inc. generates a return on equity (ROE) of 285.64% — well above the market average, a sign of a high-quality business, return on capital employed of -53.57%, an operating margin of -115.32%, a net profit margin of -135.88%.

Official website: www.scpharmaceuticals.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides